Skip to main content
. 2006 Feb 16;107(12):4834–4840. doi: 10.1182/blood-2005-08-3076

Table 1.

Clinical information about patients with T-LGL

LGL patient no. Sex Age, y Clinical presentation Abs CD8 CD4/CD8 ratio Tg Spl Vβ-Jβ restriction Vβ expansion within CD8, % Clonal size within Vβ, % Total clonal size within CD8, % Addl dx
1 F 61 Neutropenia 1430 0.91 Y N Vβ6.7-Jβ2.1 51 95 48.5 None
2* M 63 Anemia/RCA 5670 0.23 Y Y Vβ17-Jβ2.3 (Vβ3-Jβ2.1) 45 (25) 100 (100) 45 (25) UC
3* F 42 Neutropenia 9675 0.16 Y Y Vβ20-Jβ2.7 (Vβ20-Jβ2.1) 25 (25) 33 (53) 8.3 (13.3) Pulm HTN
4 F 76 Anemia/RCA 5000 0.09 Y Y Vβ17-Jβ2.3 83 100 83 None
5 M 46 Neutropenia 972 1.2 Y N Vβ4 10.5 NA NA RA
6 M 72 Neutropenia 370 2.1 Y N Vβ5.3-Jβ2.7 27 33 6.2 None
7 M 53 Neutropenia/anemia 4029 0.12 Y Y Vβ2-Jβ1.6 95 100 95 None
8 F 77 Neutropenia 4480 0.11 Y Y Vβ9-Jβ2.5 25 100 25 RA

Abs CD8 indicates absolute CD8 count; Tg, T-cell receptor gamma rearrangement; Spl, splenomegaly; Vβ, T-cell receptor variable β chain; Jβ, joining β chain of expanded clonal types; Addl dx, additional diagnoses; RCA, red cell aplasia; UC, ulcerative colitis; Pulm HTN, pulmonary hypertension; NA, not available; RA, rheumatoid arthritis.

*

There were 2 distinct clones for these patients; data in parentheses are for the second clone.

This patient had an additional minor clone (Vβ 13.1) detected as well.